Core Insights - Hyundai Motor Group has outlined its strategic vision for 2026, focusing on customer-centric transformation, enhanced ecosystem competitiveness, and AI-driven innovation to adapt to changing market dynamics and set new industry standards [1][10]. Group Priorities - The five key strategic priorities presented include customer-focused evolution, agile decision-making, ecosystem competitiveness, bold collaboration, and leading new industry standards to navigate the global landscape [2][10]. Customer-Centric Transformation - Executive Chair Chung emphasized the importance of continuous transformation driven by customer insights, stating that the ability to evolve in response to customer needs is crucial for maintaining competitiveness [4][5]. Agile Decision-Making - The company is advocating for agile decision-making and direct engagement from leaders, highlighting the need for fast and clear communication to enhance operational efficiency [6][7]. Ecosystem Competitiveness - Chung noted that the strength of the supply ecosystem is vital for competitive advantage, as the production of vehicles and humanoid robots involves thousands of components, necessitating high performance and quality across the supply chain [8][10]. AI-Driven Collaboration - The company is focusing on bold collaboration with diverse partners to navigate the AI-driven transformation in the manufacturing industry, recognizing that core product competitiveness is increasingly determined by AI capabilities [11][12]. Commitment to Innovation - Hyundai Motor Group is committed to leveraging its world-class design and manufacturing capabilities, along with valuable data from production and user experiences, to enhance its competitiveness in the physical AI field [12][13].

Core Insights - Ascletis Pharma Inc. has received Investigational New Drug (IND) clearance from the U.S. FDA for its Phase II study of ASC30, an oral small molecule GLP-1 receptor agonist for type 2 diabetes [2][5] - The Phase II study will evaluate the efficacy, safety, and tolerability of ASC30 over 13 weeks, with enrollment expected to begin in Q1 2026 [2][3] Group 1: Phase II Study for Diabetes - The Phase II study is a 13-week, randomized, double-blind, placebo-controlled, multi-center trial involving approximately 100 participants with type 2 diabetes [2][3] - Primary endpoint includes mean change from baseline in HbA1c, while secondary endpoints include changes in fasting blood glucose and body weight [2][3] - Participants will be randomly assigned to receive either ASC30 at doses of 40 mg, 60 mg, or 80 mg, or matching placebo tablets [2][3] Group 2: ASC30 Efficacy in Obesity - A recently completed Phase II study for ASC30 demonstrated placebo-adjusted weight loss of 7.7% in participants with obesity or overweight [3] - The study showed statistically significant and clinically meaningful weight reductions of 5.4%, 7.0%, and 7.7% for doses of 20 mg, 40 mg, and 60 mg, respectively [3] - ASC30 exhibited better gastrointestinal tolerability compared to other treatments, with a total treatment discontinuation rate due to adverse events of 4.8% [3] Group 3: Company Overview - Ascletis Pharma Inc. is a fully integrated biotechnology company focused on developing therapeutics for metabolic diseases [5] - The company utilizes proprietary technologies such as Artificial Intelligence-Assisted Structure-Based Drug Discovery and Ultra-Long-Acting Platform to develop drug candidates [5] - ASC30 is part of a broader pipeline that includes other candidates targeting chronic weight management and metabolic diseases [5]

Following a record-breaking Kickstarter campaign, the robotics startup unveils its final, market-ready Ascentiz- H and Ascentiz-K modules. Outdoor Adaptive Continue Reading Ascentiz's journey to CES began with a record-breaking Kickstarter campaign in November 2025, where it became the #1 Most Funded exoskeleton project and ranked 8th historically in Kickstarter's Wearable Technology category. This strong market validation underscores the demand for accessible, user-centric augmentation technology. The Asce ...

SwitchBot Smart Home 2.0 LAS VEGAS, Jan. 4, 2026 /PRNewswire/ -- SwitchBot, a leading provider of AI-enabled embodied home robotics systems, showcases its vision for smart home 2.0 at CES 2026, unveiling a lineup powered by next- generation AI robotics, fueled by core technologies the company has mastered over the years. Showcasing a deeply unified ecosystem powered by embodied AI, SwitchBot introduces a future where homes can sense, understand, and act across living, studying, working, and everything in be ...

- AWOL Vision presenta la serie Aetherion: el proyector de alcance ultracorto con triple láser 4K más nÃtido del mundo que ofrece velocidad, escala y nitidez lÃderes en la industria El primer proyector UST de triple láser que ofrece claridad 4K en tamaños de pantalla de hasta 200 pulgadas, diseñado para salas de estar inmersivas, cines en casa cinematográficos y juegos de última generación con capacidad de respuesta ultrarrápida. LAS VEGAS, 4 de enero de 2026 /PRNewswire/ -- AWOL Vision anuncia hoy la serie ...

Natural Light Optimization technology adjusts blinds throughout the day so homeowners can enjoy beautifully balanced light without lifting a finger. COOPERSBURG, Pa., Jan. 4, 2026 /PRNewswire/ -- Lutron Electronics, the trusted leader in lighting control and automated shading solutions, announces the launch of Caséta smart wood blinds. Designed for the DIY homeowner seeking convenient, connected natural light control, these blinds offer smart functionality in a classic style. Continue Reading Smart, Simple, ...

The first triple laser UST projector to deliver 4K clarity at screen sizes up to 200 inches, engineered for immersive living rooms, cinematic home theaters, and ultra-responsive next-gen gaming LAS VEGAS, Jan. 5, 2026 /PRNewswire/ -- AWOL Vision today announces the Aetherion series, including the Aetherion Max and Aetherion Pro. The lineup represents the brand's most advanced projection technology to date and is the world's sharpest 4K triple laser ultra short throw (UST) system. Built around proprietary Pi ...

Le premier projecteur UST triple laser à offrir une résolution 4K sur des écrans allant jusqu'à 200 pouces, conçu pour des salons immersifs, des home cinémas et des jeux de nouvelle génération ultra- réactifs LAS VEGAS, 4 janvier 2026 /PRNewswire/ -- AWOL Vision annonce aujourd'hui la série Aetherion, qui comprend l'Aetherion Max et l'Aetherion Pro. La gamme représente la technologie de projection la plus avancée de la marque à ce jour et constitue le système 4K triple laser à focale ultra-courte (UST) le p ...

Der erste UST-Projektor mit Dreifach-Laser, der 4K-Auflösung bei Bildschirmgrößen von bis zu 200 Zoll liefert und für immersive Wohnzimmer, Heimkinos und reaktionsschnelle Spiele der nächsten Generation entwickelt wurde LAS VEGAS, 5. Januar 2026 /PRNewswire/ -- AWOL Vision kündigt heute die Aetherion-Serie an, darunter den Aetherion Max und den Aetherion Pro. Die Produktreihe repräsentiert die bislang fortschrittlichste Projektionstechnologie der Marke und ist das weltweit schärfste 4K-Triple-Laser- Ultraku ...

®RPC inside G120 Subsystem – Honored with the "2025 Hsinchu Science Park Innovative Product Award." Privacy-First AI Robot Decision System – Winner of the CES Innovation Award. Launch of Robotics Barebone Platforms – Introducing the AMR01C and AMR01M series. XINK Nano Platform –Successfully deployed in smart parking applications by Taiwan's leading EV charging system integrator. Strategic Partnership with Asia Optical – Collaborating to create domestic delivery and robotic base barebone systems. New Scalabl ...